Notices and Reminders
NIH Data Management and Sharing (DMS) Plan: New Requirement from the Office of Research Administration (ORA)
The project’s Principal Investigator (PI) is required to monitor and manage the DMS Plan, with at least yearly examination and oversight of data sharing and storage at the time of the Research Performance Progress Report (RPPR). To ensure compliance with NIH DMS guidelines, the following language for element 6, Oversight of Data Management and Sharing was developed by the ORA and MUST be included in your DMS Plan:
The Principal Investigator (PI) for this project, Dr. ABC, will ensure that this Data Management and Sharing (DMS) Plan is followed. The PI will be responsible for oversight of compliance with the accepted DMS Plan. Compliance will be evaluated annually during the award period by Ashley Krukowski, the Associate Vice President for Research Administration, and progress towards the plan’s DMS activities will be included in the annual Research Performance Progress Report (RPPR) submitted to the National Institute of XXXX Project Officer. At the project conclusion, the final progress report will summarize how the DMS objectives were fulfilled and provide links to the shared dataset(s).
Workshops and Seminars
Librarian Education & Research Fall Symposium
Date: October 26, 2023
Location: Faculty Atrium, Bird Health Sciences Library
Open to all OUHSC faculty, students, and staff. Enjoy food, fun, and fellowship! Come for a session or stay for the day!
Additional Information: Please see the attached flyer (NMLM_Event_26OCT2023)
Lunch & Learn: Patents 101: First Do No Harm
How to Write and Speak about Your Invention Without Losing U.S. or Foreign Patent Rights
Date: October 25, 2023; 12:00 p.m. (CDT)
About this Event: Learn critical information about how to protect your invention and your patent rights. This month’s speaker is Dr. Chris Corbett, Director of Intellectual Property for OTC.
Topics
-
What is a patent and what does a patent protect?
-
Patenting in a university.
-
Requirements for patentability.
-
What is “prior art”?
-
What is a public disclosure?
-
How to publish without hurting your patent rights.
-
Key milestones of the patenting process.
Office of Technology Commercialization Website:
ou.edu/otc
2023 END2Cancer Conference - Register and Submit Abstracts
Date: November 30 – December 1, 2023
Description: OU Health Stephenson Cancer Center is proud to host the sixth annual in-person 2023 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference on Nov. 30 - Dec. 1, 2023 in Oklahoma City, Oklahoma, USA.
In its sixth year, the END2CANCER conference will start the morning of November 30, 2023 and conclude in the afternoon of December 1, 2023. The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside. Topics to be discussed in the planned thematic sessions include Gene, mRNA, and Drug Delivery, Molecular Signaling and Targets for Therapy, Extracellular Vesicles and Tumor Signaling, Tissue Engineering and Biomimetics, Artificial Intelligence and Application in Cancer, Cancer Metabolism, and Immuno-Oncology/Immunotherapy.A special session on "Training and Career Development Grant Opportunities from the NCI" will be presented by the Director of the Center for Cancer Training at the National Cancer Institute, Dr. Oliver Bogler.
High school, undergraduate, graduate, medical school, dental school, pharmacy, nursing, engineering students and fellows (residents, post-doctoral and clinical fellows), among others working in any area of cancer-related research are invited to register to attend and present their research work during our poster presentations and compete for awards.
The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high school and college students, patient advocates, business professionals, educators and technology transfer specialists.
A special scientific photo session titled "Art of Science in Light of Nanomedicine" will allow participants (research staff, students and fellows) to display their best research as a photo with a catchy non-scientific caption and compete for a prize.
12th International Conference on Computational Advances in Bio and Medical Sciences (ICCABS 2023)
This symposium be hosted by the Oklahoma University Norman Campus from December 11
th to 13
th 2023. This leading conference in bioinformatics and computational biology is hosting 4 workshops on next generation sequencing, molecular epidemiology, single cell omics, and systems immunology. The conference will have post-proceedings and extended abstracts published in Springer Lecture Notes in Bioinformatics (LNBI) and selected submissions will be invited to special issues of the Journal of Computational Biology (JCB) or Transactions on Computational Biology and Bioinformatics (TCBB) dedicated to the conference. The conference will have a poster session and a networking event. Highlight talks of published works or research in progress are also welcomed. Please visit the conference website (
https://iccabs.cs.ou.edu/) and consider the CFP for more details. A number of student scholarships and 20% discount is offered for OU affiliate faculty and students for registration fees support.
ORA Training: Introduction to Proposal Preparation & ORA Submission Process
Date: October 31, 2023; 11:00 AM - 12:00 PM
Location: Zoom
Description: This session will provide an overview of OUHSC grants policies and procedures, budget development, and grant submission process.
Oklahoma Conference for Statistical Innovation and Application
American Statistical Association Oklahoma Chapter, Department of Biostatistics and Epidemiology at OUHSC, and Oklahoma Shared Clinical and Translational Research co-organized the second Oklahoma Conference for Statistical Innovation and Application in the Era of Data Science which will be held at Hudson College of Public Health in Oct 23
rd and Oct 24
th. The conference invites 11 well established guest speakers and it also includes student poster competition session. The conference will be in hybrid format including both in-person and zoom options. The theme of the conference is the novel development in biostatistics, statistics, data science and their applications in biomedical research. Registration is needed at the following website for attending the conference:
https://obsc.ouhsc.edu/.
OUHSC Funding Opportunities
Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications
The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques.
W. M. Keck Foundation Research Program
The W. M. Keck Foundation is a private foundation supporting fundamental research in two specific areas: 1. science and engineering, and 2. medical research. The Foundation’s Research Program (
https://www.wmkeck.org/research-overview/) seeks to benefit humanity by supporting projects that are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field. Applicants are asked to submit a
Notice-of-Intent (NOI) by 5 p.m. on November 1, so that a qualified review panel can be convened.
A one-page concept paper and cv should be submitted by 5 p.m. on November 10, stipulating the area of focus: science and engineering, or medical research. Applicants will be notified by December 15 regarding the results of the internal competition. Phase I applications to the Keck Foundation are due by 4:30 p.m. PT on May 1, 2024. Please see the attached call for applications for details (OUHSC Announcement Keck Foundation 2023-24).
Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click
here for more information, or email
otc@ou.edu or
gina-mcmillen@ouhsc.edu).
-
A top five pharmaceutical company is looking to identify protein engineering research and technologies that support the development of therapeutics with bi/multi-specific conditional activity. Approaches of interest include activation by specific pH, proteases, small molecule or ligand binding; structural occlusion mechanisms and other novel mechanism to achieve conditional activation. Submission entails a one-page 200-300 word non-confidential brief. Deadline 10/30.
-
A multinational pharmaceutical company is seeking novel biology or therapeutic compounds for treatment of Immunology and Inflammation diseases (i.e. asthma, COPD, IBD). Novel first-in-class or best-in-class preferred; small molecule, large molecule and RNA modalities are of highest interest. Out of scope: drug repurposing, natural products and herbal medicine. Submission entails a one-page 200-300 word non-confidential brief. Deadline 10/30.
NOTE: If the project is selected to move forward with a full application, it will need to be routed through SoonerTrack II.
NIH Notices
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities
Other Funding Opportunities
Route 66 Endometrial Cancer SPORE: Developmental Research Program
Description: The Developmental Research Program within the Route 66 Endometrial Cancer SPORE seeks applications developing bold new ideas in endometrial cancer research. Projects at the pilot stage investigating new treatment or prevention strategies and/or obtaining preliminary data are encouraged to apply.
Application Deadline: October 27, 2023
Link to the Full Announcement: Please see attached (SPORE_DRP_RFP_2023)
Route 66 Endometrial Cancer SPORE: Career Enhancement Program
Description: This program is for Early career faculty or established investigators who wish to develop or refocus their careers on translational research in endometrial cancer with emphasis on etiology, prevention, diagnosis, early detection, treatment, endometrial cancer disparities, or population science, and Senior level post-doctoral or clinical fellows who provide a letter from their Department Chair or Division Director stating that candidate will join its faculty by the time of the award.
Application Deadline: October 27, 2023
Link to the Full Announcement: Please see attached (SPORE_CEP_RFP_2023)
Chan Zuckerberg Initiative (CZI) Request for Applications: Single-Cell Biology Data Insights Cycle 3 RFA
Description: The Chan Zuckerberg Initiative (CZI) invites applications for Cycle 3 of the
Single-Cell Biology Data Insights RFA. CZI seeks to support projects that will advance the fields of single-cell biology and data science. Projects may include dedicated efforts to democratize access and usability of existing single-cell datasets, demonstrate utility by leveraging existing single-cell datasets to address impactful and challenging biological questions, and develop methods that enable greater biological insight and other major challenges brought forward.
This request for applications is the last of three currently planned cycles, with successful projects receiving 18 months of funding support. Awards are a maximum of $400,000 in total costs for Expanded Projects, and $200,000 in total costs for Focused Projects.
Application Deadline: December 5, 2023
Susan G. Komen ASPIRE: A Supplement to Promote Inclusion for Research Excellence
Description: This new Susan G. Komen grant is intended to enhance the diversity of the breast cancer research workforce by providing established breast cancer scientists with supplemental funding to support research trainees from communities historically minoritized and marginalized in research. By supporting these promising trainees early in their research careers, Komen seeks to ensure that a diverse group of highly trained scientists who reflect the communities we serve will emerge as the next generation of leaders in breast cancer research and end breast cancer forever.
Eligibility: Lead mentor must have a currently funded breast cancer research project that has undergone a rigorous peer review (see request for application for link of organizations that fall under this category). Trainees supported with this supplement are from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data. This includes individuals who identify as Black or African American, Latino or Hispanic, American Indian or Alaska Native, Native Hawaiian and other Pacific Islanders; individuals with disabilities; and individuals from disadvantaged backgrounds according to the criteria used by the NIH (https://diversity.nih.gov/about-us/population-underrepresented). Eligibility for disadvantaged background will be measured using the same characteristics as the NIH, i.e., at least two of the criteria must be met to be included.
Award amount: up to $100,000 per year to cover a trainee’s salary for one year or two years.
Full Application Due: November 1, 2023, by 1 p.m., Eastern Standard Time